Cream trial aims to smooth facial bumps in rare genetic disorder
Symptom relief
Terminated
This study tested whether a cream containing the drug sirolimus could safely reduce the facial bumps (angiofibromas) common in children with tuberous sclerosis complex (TSC). About 45 children and young adults applied one of two strengths of the cream or a placebo cream to their …
Phase: PHASE2 • Sponsor: Aucta Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC